Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuCycle Therapy, Inc. was a biotechnology company specializing in "plant molecular farming," utilizing plants as bioreactors to produce therapeutic proteins and high-value nutraceuticals. The company developed a proprietary platform for the transient expression of recombinant proteins and the hydroponic cultivation of mineral-enriched plants, such as Brassica juncea. Its clinical pipeline included plant-derived vaccines for anthrax and malaria, developed in collaboration with the U.S. Navy and Fraunhofer USA. Additionally, NuCycle commercialized a line of phytomineral supplements, including selenium-enriched products for cancer chemoprevention. The company was acquired by Integrated BioPharma in 2002 and continued to operate as a subsidiary focused on biotechnology and nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuCycle Therapy.